InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding InflaRx N.V. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 42 | 39 | −3 |
| Shares | 19.0M | 17.1M | −1.95M (−10.3%) |
| Value | $56.8M | $27.8M | −$28.9M (−51.0%) |
New holders (5)
Institutions that held InflaRx N.V. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 39,130 | $63.8K | 0.00% |
| Two Sigma Advisers, LP | 24,900 | $40.6K | 0.00% |
| Squarepoint Ops LLC | 11,652 | $19.0K | 0.00% |
| Advisor Group Holdings, Inc. | 8,700 | $14.2K | 0.00% |
| Wetzel Investment Advisors, Inc. | 1,000 | $2.00K | 0.00% |
Sold out (8)
Institutions that held InflaRx N.V. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Velan Capital Investment Management LP | 200,000 | $596.0K |
| Woodline Partners LP | 130,293 | $388.3K |
| J. Goldman & Co LP | 108,001 | $321.8K |
| Alps Advisors Inc | 83,279 | $307.0K |
| Prelude Capital Management, LLC | 55,192 | $164.5K |
| XTX Topco Ltd | 14,588 | $43.5K |
| Group One Trading, L.P. | 3,831 | $11.4K |
| UBS Group AG | 463 | $1.38K |